ANI Pharmaceuticals, Inc. (BST:BSFA)
Germany flag Germany · Delayed Price · Currency is EUR
74.50
+3.00 (4.20%)
At close: Aug 13, 2025

ANI Pharmaceuticals Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
1,5011,043952614678285
Upgrade
Market Cap Growth
-3.58%9.52%55.11%-9.53%138.20%-56.40%
Upgrade
Enterprise Value
1,8681,5291,063855850437
Upgrade
Last Close Price
76.0051.0048.6037.6040.8022.40
Upgrade
PE Ratio
--68.00---
Upgrade
PS Ratio
2.361.762.162.073.571.67
Upgrade
PB Ratio
3.822.522.301.942.151.78
Upgrade
P/TBV Ratio
--5.3819.3964.9496.52
Upgrade
P/FCF Ratio
14.0522.599.56-1008.4338.15
Upgrade
P/OCF Ratio
12.6716.868.85-232.2322.82
Upgrade
EV/Sales Ratio
2.932.582.412.894.472.57
Upgrade
EV/EBITDA Ratio
20.4719.2310.7526.9350.6418.40
Upgrade
EV/EBIT Ratio
110.44108.3123.73---
Upgrade
EV/FCF Ratio
17.4933.1410.67-1263.3158.56
Upgrade
Debt / Equity Ratio
1.361.470.620.850.801.02
Upgrade
Debt / EBITDA Ratio
5.887.442.618.2615.066.87
Upgrade
Debt / FCF Ratio
5.0113.202.60-375.6521.88
Upgrade
Asset Turnover
0.660.560.590.410.350.45
Upgrade
Inventory Turnover
2.212.021.681.481.411.60
Upgrade
Quick Ratio
1.901.932.632.152.611.32
Upgrade
Current Ratio
2.552.733.573.463.682.17
Upgrade
Return on Equity (ROE)
-2.17%-4.18%4.72%-13.74%-15.37%-11.04%
Upgrade
Return on Assets (ROA)
1.09%0.83%3.72%-2.10%-2.86%-2.12%
Upgrade
Return on Capital (ROIC)
1.33%1.01%4.52%-2.53%-3.38%-2.43%
Upgrade
Return on Capital Employed (ROCE)
1.80%1.30%6.50%---
Upgrade
Earnings Yield
-0.72%-1.72%1.79%-7.30%-5.52%-6.47%
Upgrade
FCF Yield
7.12%4.43%10.46%-6.11%0.10%2.62%
Upgrade
Payout Ratio
--8.65%---
Upgrade
Buyback Yield / Dilution
-0.97%-6.18%-11.89%-29.09%-5.28%0.63%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.